US FDA panel back traditional approval for Eisai-Biogen's Alzheimer's drug Leqembi

A panel of expert advisers on Friday
unanimously agreed that a late-stage clinical trial of Eisai
and Biogen's Leqembi verified the benefit of
the treatment for Alzheimer's disease, clearing the way... | June 9, 2023

Related Keywords

Bengaluru ,Karnataka ,India ,Leroy Leo ,Jonathan Oatis ,Reuters ,Biogen Inc Stock Exchange ,News ,Information ,Press Release , ,Panel ,F ,Expert ,Advisers ,N ,Greed ,Hat ,Linical ,Trial ,Leqembi ,Verified ,The ,Benefit ,Treatment ,Or ,Clearing ,He Biib Us09062x1037 ,